Dr. LIU Dongming is the Chief Physician of Urology at Renji Hospital, affiliated with the Shanghai Jiao Tong University School of Medicine, a Professor, and a Master's Supervisor. He studied under Professor Jiang Yu, a leading figure in Chinese urology, and from 1992 to February 1994, he trained under the internationally renowned urologist Professor F. Pagano at the Urological Research Institute of the University of Padova in Italy. Dr. LIU is the pioneer of laparoscopic surgery in the urology department at Renji Hospital, and his medical team has since accumulated over 20,000 cases of various laparoscopic surgeries. He also serves as a Visiting Professor at the Urological Research Institute of the University of Padova, a Visiting Scholar at the University of California, San Francisco (UCSF), the Deputy Head of the Shanghai Minimally Invasive Urology Group, and a Senior Expert at the Shanghai Urological Disease Consultation Center.

With over 30 years of clinical experience in urology, Dr. LIU is highly skilled in the diagnosis and treatment of urological diseases, specializing in minimally invasive urological surgeries, particularly for urological tumors. This includes laparoscopic surgeries for complex renal tumors, adrenal diseases, prostate and bladder tumors, as well as surgical treatments for complex renal cell carcinoma, bilateral renal tumors, solitary renal tumors, tumors with vena cava tumor thrombi, and large adrenal tumors. Dr. Liu was the first to propose the concept of targeted renal tumor vessels and pioneered the 3D imaging technique for zero-ischemia laparoscopic kidney-sparing surgery for renal tumors. To date, he has performed over 500 such surgeries.